Schellini, Silvana Artioli [UNESP]Silva, Maria Rosa Bet de Moraes [UNESP]Manetti, L. D. [UNESP]Padovani, Carlos Roberto [UNESP]2014-05-272014-05-271999-01-01Revista Brasileira de Oftalmologia, v. 58, n. 1, p. 27-31, 1999.0034-7280http://hdl.handle.net/11449/65703The aim of this study was evaluate the effectiveness of the sodium diclophenac on the mydriasis induced by drugs and on the tearing, blepharospasm and photophobia in normal individuals that received mydriatic or cycloplegic eyedrops. We observed that there was not increase of the pupil diameter with the use of the diclophenac (f = 0,52). The photophobia symptom was mainly present in the patients with dark iris and that received the cycloplegic drops (p < 0,01). The authors concluded that there is not benefit in the use of the sodium dyclophenac eyedrops for the mydriasis increase or the decrease of the ocular symptoms in routine ophthalmologic examination.27-31porMydriasisNon hormonal anti-inflammatory eyedropsPhotophobiaSodium dyclophenacdiclofenacaccommodation paralysisblepharospasmdrug effectfemalehumanlacrimationmajor clinical studymalemydriasisphotophobiapupilArtigoAcesso restrito2-s2.0-003298209194202491008354925988776856320701